Stay updated on Gantenerumab in Early Alzheimer's Disease Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab in Early Alzheimer's Disease Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the Phase 3 gantenerumab study in early Alzheimer’s disease is displayed, including its terminated status, study design, eligibility criteria, locations, outcome measures, results, and study documents.
    Difference
    100%
    Check dated 2026-11-10T20:44:32.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T21:27:52.000Z thumbnail image
  3. Check
    26 days ago
    Change Detected
    Summary
    A site-wide notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page, and the site revision identifier is updated.
    Difference
    1%
    Check dated 2026-10-20T21:57:45.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T21:53:05.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record instead of the usual content, indicating that access to the record is blocked.
    Difference
    18%
    Check dated 2026-09-22T22:52:23.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A new study location San Martin de Porres, Peru, 15102 was added and the San Martín de Porres entry was removed. The page revision was updated from v3.6.6 to v3.7.0.
    Difference
    0.0%
    Check dated 2026-09-15T20:55:33.000Z thumbnail image

Stay in the know with updates to Gantenerumab in Early Alzheimer's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.